Celularity Inc. Variable Lease, Cost
Celularity Inc. (CELU) reported Variable Lease, Cost of $1.51 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-04-30
- Celularity Inc. variable lease, cost for the quarter ending 2025-12-31 was $362.00K, a 12.42% increase year-over-year.
- Celularity Inc. variable lease, cost for the quarter ending 2025-09-30 was $345.00K, a 0.86% decline year-over-year.
- Celularity Inc. variable lease, cost for the quarter ending 2025-06-30 was $340.00K, a 8.63% increase year-over-year.
- Celularity Inc. variable lease, cost for the quarter ending 2025-03-31 was $461.00K, a 26.30% increase year-over-year.
- Celularity Inc. variable lease, cost for fiscal 2025 was $1.51M, a 11.94% increase from fiscal 2024.
- Celularity Inc. variable lease, cost for fiscal 2024 was $1.35M, a 118981.27% increase from fiscal 2023.
- Celularity Inc. variable lease, cost for fiscal 2023 was $1.13K, a 99.93% decline from fiscal 2022.
- Celularity Inc. variable lease, cost for fiscal 2022 was $1.60M.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month | Variable Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $707.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.05M derived: sum of 3 quarters · filed 2026-04-30 | $1.51M 10-K · filed 2026-04-30 | |
| 2025-09-30 | $345.00K 10-Q · filed 2025-11-14 | $685.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.15M 10-Q · filed 2025-11-14 | $1.47M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2025-06-30 | $340.00K 10-Q · filed 2025-08-29 | $801.00K 10-Q · filed 2025-08-29 | $1.12M derived: sum of 3 quarters · filed 2026-04-30 | $1.47M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2025-03-31 | $461.00K 10-Q · filed 2025-08-29 | $783.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.13M derived: sum of 3 quarters · filed 2026-04-30 | $1.44M derived: sum of 4 quarters · filed 2026-04-30 | |
| 2024-12-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $670.00K derived: sum of 2 quarters · filed 2026-04-30 | $983.00K derived: sum of 3 quarters · filed 2026-04-30 | $1.35M 10-K · filed 2026-04-30 | $1.35K 10-K · filed 2025-05-08 |
| 2024-09-30 | $348.00K 10-Q · filed 2025-11-14 | $661.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.03M 10-Q · filed 2025-11-14 | $116.13K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $313.00K 10-Q · filed 2025-08-29 | $678.00K 10-Q · filed 2025-08-29 | -$231.87K derived: sum of 3 quarters · filed 2025-08-29 | $88.13K derived: sum of 4 quarters · filed 2025-08-29 | |
| 2024-03-31 | $365.00K 10-Q · filed 2025-08-29 | -$544.87K derived: sum of 2 quarters · filed 2025-08-29 | -$224.87K derived: sum of 3 quarters · filed 2025-08-29 | $61.13K derived: sum of 4 quarters · filed 2025-08-29 | |
| 2023-12-31 | -$909.87K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | -$589.87K derived: sum of 2 quarters · filed 2025-05-08 | -$303.87K derived: sum of 3 quarters · filed 2025-05-08 | $1.13K 10-K · filed 2025-05-08 | $1.13M 10-K · filed 2024-07-30 |
| 2023-09-30 | $320.00K 10-Q · filed 2024-12-06 | $606.00K derived: sum of 2 quarters · filed 2024-12-06 | $911.00K 10-Q · filed 2024-12-06 | $1.37M derived: sum of 4 quarters · filed 2024-12-06 | |
| 2023-06-30 | $286.00K 10-Q · filed 2024-11-07 | $591.00K 10-Q · filed 2024-11-07 | $1.05M derived: sum of 3 quarters · filed 2024-11-07 | $1.50M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-03-31 | $304.00K 10-Q · filed 2024-10-16 | $762.00K derived: sum of 2 quarters · filed 2024-10-16 | $1.21M derived: sum of 3 quarters · filed 2024-10-16 | $1.58M derived: sum of 4 quarters · filed 2024-10-16 | |
| 2022-12-31 | $458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $906.00K derived: sum of 2 quarters · filed 2024-07-30 | $1.27M derived: sum of 3 quarters · filed 2024-07-30 | $1.60M 10-K · filed 2024-07-30 | |
| 2022-09-30 | $448.00K 10-Q · filed 2024-01-03 | $815.00K derived: sum of 2 quarters · filed 2024-01-03 | $1.14M 10-Q · filed 2024-01-03 | ||
| 2022-06-30 | $367.00K 10-Q · filed 2023-08-14 | $692.00K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $325.00K 10-Q · filed 2023-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |